Sage Journals: Discover world-class research

Abstract

Angiotensin II (Ang II) causes facilitation of sympathetic neurotransmission via prejunctionallylocated AT₁-receptors. The pithed rat is a suitable model to study the interactions between endogenously produced Ang II and the sympathetic nervous system at the peripheral level. Previously, we demonstrated that inhibition of the facilitatory actions of Ang II is a class effect of all AT₁-receptor blockers (ARB). However, all ARBs caused less than maximal inhibition after the highest dose, thus causing a U-shaped dose-response curve with respect to sympatho-inhibition. In the present study, we investigated whether the AT₂-receptor is involved in this `upturn' of the dose-response relationship. Accordingly, we studied the effect of the ARB, irbesartan (1—60 mg/kg), on the sequelae of electric stimulation of the thoraco-lumbar sympathetic outflow in the presence and absence of the AT₂blocker, PD 123319 (0.5 mg/kg +50 µg/kg/min). Additionally, the effect of the combined (non-selective) AT₁/AT₂-receptor antagonist saralasin (0.001, 0.003, 0.01 or 0.03 mg/kg/min), on stimulation-induced responses was studied. In addition, we measured PRA-levels after administration of irbesartan, in this model.

The stimulation-induced increase in diastolic blood pressure (DBP) could be dose-dependently reduced by irbesartan. Co-infusion with PD 123319 increased the sympatho-inhibitory potency of irbesartan, possibly through displacement of irbesartan from plasma protein binding sites. The U-shaped dose-response relationship observed with irbesartan, which is illustrative for other ARBs in this model, was not observed when PD 123319 was co-administered with irbesartan, nor with the non-selective AT₁/AT₂blocker, saralasin. PRA-levels increased from 111.0±17.8 to 198.7±22.2 ng/ml/hour after administration of irbesartan. PRA-levels did not differ when measured after the three highest doses of irbesartan.

Conclusions The present findings indicate a facilitatory role for the AT₂-receptor, which is unmasked by the highest dose of irbesartan. Different plasma Ang II-levels are unlikely to have caused the less than maximal inhibition after the highest dose of irbesartan.

Keywords

PD 123319 irbesartan AT2- and AT1-receptor blockade pithed rat sympathetic neurotransmission

Get full access to this article

View all access options for this article.

References

Reid IA Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol 1992;262:E763-E778.

Kaufman LJ , Vollmer RR Endogenous angiotensin II facilitates sympathetically mediated hemodynamic responses in pithed rats. J Pharmacol Exp Ther 1985;235:128-34.

Wong PC , Bernard R. , Timmermans PB Effect of blocking angiotensin II receptor subtype on rat sympathetic nerve function. Hypertension 1992;19:663-7.

Hauser W. , Dendorfer A. , Nguyen T. , Dominiak P. Effects of the AT1 antagonist HR 720 in comparison to losartan on stimulated sympathetic outflow, blood pressure, and heart rate in pithed spontaneously hypertensive rats. Kidney Blood Press Res 1998;21:29-35.

Ferrario CM , Gildenberg PL , McCubbin JW Cardiovascular effects of angiotensin mediated by the central nervous system . Circ Res 1972;30:257-62.

Knape JT , van Zwieten PA Positive chronotropic activity of angiotensin II in the pithed normotensive rat is primarily due to activation of cardiac beta 1- adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 1988;338:185-90.

Whitebread S. , Mele M. , Kamber B. , de Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989;163: 284-91.

Dudley DT , Panek RL , Major TC et al. Subclasses of angiotensin II binding sites and their functional significance. Mol Pharmacol 1990;38:370-7.

de Gasparo M. , Catt KJ , Inagami T. , Wright JW , Unger T. International Union of Pharmacology. XXIII.The angiotensin II receptors. Pharmacol Rev 2000 ;52:415-72.

10.

Timmermans PB , Wong PC , Chiu AT et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993 ;45:205-51.

11.

Horiuchi M. , Akishita M. , Dzau VJ Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 1999;33:613-21.

12.

Balt JC , Mathy MJ , Pfaffendorf M. , van Zwieten PA Inhibition of AngII-induced facilitation of sympathetic neurotransmission in the pithed rat; a comparison between losartan, irbesartan, telmisartan and captopril.JHypertens 2001;19:465-73.

13.

Balt JC , Mathy MJ , Pfaffendorf M. , van Zwieten PA Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan.JHypertens 2001;19:2241-50.

14.

Cox SL , Story DF , Ziogas J. Multiple prejunctional actions of angiotensin II on noradrenergic transmission in the caudal artery of the rat. Br J Pharmacol 1996;119:976-84.

15.

Balt JC , Mathy MJ , Pfaffendorf M. , van Zwieten PA Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril. J Hypertens 2001;19:465-73.

16.

Goodman Gilman, A. The Pharmacological Basis of Therapeutics 10th Edition. 812. 2001. McGraw Hill.

17.

Macari D. , Bottari S. , Whitebread S. , de Gasparo M. , Levens N. Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted rat. Eur J Pharmacol 1993;249:85-93.

18.

Hollemans HJ , van der MJ, Kloosterziel W. Measurement of renin activity in plasma by a radioimmunoassay for angiotensin I. Clin Chim Acta 1969;24:353-7.

19.

Tofovic SP , Pong AS , Jackson EK Effects of angiotensin subtype 1 and subtype 2 receptor antagonists in normotensive versus hypertensive rats.Hypertension 1991 ;18:774-82.

20.

Brasch H. , Sieroslawski L. , Dominiak P. Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype 1 receptors. Hypertension 1993;22:699-704.

21.

Wong PC , Christ DD , Timmermans PB Enhancement of losartan (DuP 753)-induced angiotensin II receptor antagonism by PD123177 in rats. Eur J Pharmacol 1992;20:267-70.

22.

Collister JP , Soucheray SL , Osborn JW Chronic hypotensive effects of losartan are not dependent on the actions of angiotensin II at AT2 receptors. J Cardiovasc Pharmacol 2002 ;39:107-16.

23.

Arima S. , Endo Y. , Yaoita H. et al. Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 1997 ;100:2816-23.

24.

Gigante B. , Piras O. , De Paolis P. , Porcellini A. , Natale A. , Volpe M. Role of the angiotensin II AT2-subtype receptors in the blood pressure-lowering effect of losartan in salt-restricted rats. J Hypertens 1998;16:2039-43.

25.

Siragy HM , de Gasparo M. , Carey RM Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats. Hypertension 2000;35:1074-7.

26.

Carey RM , Howell NL , Jin XH , Siragy HM Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats. Hypertension 2001;38:1272-7.

27.

de Jonge A. , Knape JT , van Meel JC et al. Effect of converting enzyme inhibition and angiotensin receptor blockade on the vasoconstriction mediated by alpha 1-and alpha 2- adrenoceptor stimulation in pithed normotensive rats. Naunyn Schmiedebergs Arch Pharmacol 1982;321:309-13.

Involvement of the AT2-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission

Abstract

Keywords

Get full access to this article

References